Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Malm

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Psychopharmacology|January 1, 1980
Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthateD Wiles, M Franklin, S J Dencker, et al.
Nordic Journal of Psychiatry|February 28, 2002
Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat)E Lindström, T Lewander, U Malm, et al.
Lakartidningen|July 24, 1991
[Time for an efficiency assessment system for patients with schizophrenia]T Nordén, M Arnlind, R Blecher, et al.
Nordic Journal of Psychiatry|February 28, 2002
Assessment of patient satisfaction with psychiatric care. Development and clinical evaluation of a brief consumer satisfaction rating scale (UKU-ConSat)U G Ahlfors, T Lewander, E Lindström, et al.
Pharmacopsychiatry|November 1, 1990
The development of an observer-scale for measuring social dysfunction and aggressionB Wistedt, A Rasmussen, L Pedersen, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1973
Clinical experience with 19.552 R.P. in Nordic countriesP Kristjansen, S J Dencker, J Elley, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1973
Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigationP Kristjansen, S J Dencker, J Elley, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1985
Patients admitted for compulsory treatment to selected psychiatric units in Italy and in SwedenC Perris, D Kemali, S J Dencker, et al.
Schizophrenia Bulletin|January 1, 1990
Defining treatment refractoriness in schizophreniaH D Brenner, S J Dencker, M J Goldstein, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Psychopharmacology|January 1, 1980
Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthateD Wiles, M Franklin, S J Dencker, et al.
Nordic Journal of Psychiatry|February 28, 2002
Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat)E Lindström, T Lewander, U Malm, et al.
Lakartidningen|July 24, 1991
[Time for an efficiency assessment system for patients with schizophrenia]T Nordén, M Arnlind, R Blecher, et al.
Nordic Journal of Psychiatry|February 28, 2002
Assessment of patient satisfaction with psychiatric care. Development and clinical evaluation of a brief consumer satisfaction rating scale (UKU-ConSat)U G Ahlfors, T Lewander, E Lindström, et al.
Pharmacopsychiatry|November 1, 1990
The development of an observer-scale for measuring social dysfunction and aggressionB Wistedt, A Rasmussen, L Pedersen, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1973
Clinical experience with 19.552 R.P. in Nordic countriesP Kristjansen, S J Dencker, J Elley, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1973
Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigationP Kristjansen, S J Dencker, J Elley, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1985
Patients admitted for compulsory treatment to selected psychiatric units in Italy and in SwedenC Perris, D Kemali, S J Dencker, et al.
Schizophrenia Bulletin|January 1, 1990
Defining treatment refractoriness in schizophreniaH D Brenner, S J Dencker, M J Goldstein, et al.
Pageof 5